Edwards Lifesciences Corp (EW)
65.49
+0.12
(+0.18%)
USD |
NYSE |
Oct 04, 16:00
65.48
-0.01
(-0.02%)
After-Hours: 20:00
Edwards Lifesciences SG&A Expense (Annual): 1.825B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.825B |
| December 31, 2022 | 1.568B |
| December 31, 2021 | 1.494B |
| December 31, 2020 | 1.228B |
| December 31, 2019 | 1.242B |
| December 31, 2018 | 1.088B |
| December 31, 2017 | 990.80M |
| December 31, 2016 | 904.70M |
| December 31, 2015 | 850.70M |
| December 31, 2014 | 858.00M |
| December 31, 2013 | 733.40M |
| December 31, 2012 | 697.40M |
| December 31, 2011 | 642.40M |
| Date | Value |
|---|---|
| December 31, 2010 | 550.00M |
| December 31, 2009 | 508.80M |
| December 31, 2008 | 480.60M |
| December 31, 2007 | 418.00M |
| December 31, 2006 | 376.00M |
| December 31, 2005 | 349.00M |
| December 31, 2004 | 319.90M |
| December 31, 2003 | 289.90M |
| December 31, 2002 | 227.90M |
| December 31, 2001 | 203.00M |
| December 31, 2000 | 216.00M |
| December 31, 1999 | 233.00M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.228B
Minimum
2020
1.825B
Maximum
2023
1.471B
Average
1.494B
Median
2021
SG&A Expense (Annual) Benchmarks
| Boston Scientific Corp | 5.19B |
| Becton Dickinson & Co | 4.719B |
| Teleflex Inc | 929.87M |
| NeuroOne Medical Technologies Corp | 6.926M |
| Nutriband Inc | 3.774M |